Caligan Partners LP Diversified Active

CIK: 0001727492 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $315,473 (100.0% shares, 0.0% debt)

Holdings (12)

LQDA LIQUIDIA CORPORATION 25.7%

Value ($000) $81,186 Shares 8,118,592 Est. Cost $5.57 Unrealized +96.1%

— VERONA PHARMA PLC 13.1%

Value ($000) $41,339 Shares 1,436,878 Est. Cost $16.60 Unrealized —

EXEL EXELIXIS INC 12.6%

Value ($000) $39,593 Shares 1,525,730 Est. Cost $19.42 Unrealized +28.0%

EOLS EVOLUS INC 11.3%

Value ($000) $35,535 Shares 2,193,488 Est. Cost $9.83 Unrealized +42.1%

ANIK ANIKA THERAPEUTICS INC 11.2%

Value ($000) $35,448 Shares 1,435,130 Est. Cost $25.57 Unrealized +1.4%

AGIO AGIOS PHARMACEUTICALS INC 8.2%

Value ($000) $25,757 Shares 579,717 Est. Cost $26.07 Unrealized +74.2%

BCRX BIOCRYST PHARMACEUTICALS INC 6.2%

Value ($000) $19,635 Shares 2,583,585 Est. Cost $5.54 Unrealized +37.3%

— Y-MABS THERAPEUTICS INC 5.0%

Value ($000) $15,718 Shares 1,195,253 Est. Cost $10.05 Unrealized —

MLYS MINERALYS THERAPEUTICS INC 3.8%

Value ($000) $11,882 Shares 981,155 Est. Cost $12.48 Unrealized -3.0%

NBP I MAB 1.4%

Value ($000) $4,339 Shares 3,499,330 Est. Cost $1.70 Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 1.1%

Value ($000) $3,341 Shares 322,453 Est. Cost $13.28 Unrealized -1.5%

OTLK OUTLOOK THERAPEUTICS INC 0.5%

Value ($000) $1,702 Shares 318,699 Est. Cost $8.09 Unrealized -9.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
LQDA	LIQUIDIA CORPORATION	8,118,592	$81,186	25.7%	$5.57	+96.1%	COM NEW	53635D202
—	VERONA PHARMA PLC	1,436,878	$41,339	13.1%	$16.60	—	SPONSORED ADS	925050106
EXEL	EXELIXIS INC	1,525,730	$39,593	12.6%	$19.42	+28.0%	COM	30161Q104
EOLS	EVOLUS INC	2,193,488	$35,535	11.3%	$9.83	+42.1%	COM	30052C107
ANIK	ANIKA THERAPEUTICS INC	1,435,130	$35,448	11.2%	$25.57	+1.4%	COM	035255108
AGIO	AGIOS PHARMACEUTICALS INC	579,717	$25,757	8.2%	$26.07	+74.2%	COM	00847X104
BCRX	BIOCRYST PHARMACEUTICALS INC	2,583,585	$19,635	6.2%	$5.54	+37.3%	COM	09058V103
—	Y-MABS THERAPEUTICS INC	1,195,253	$15,718	5.0%	$10.05	—	COM	984241109
MLYS	MINERALYS THERAPEUTICS INC	981,155	$11,882	3.8%	$12.48	-3.0%	COM	603170101
NBP	I MAB	3,499,330	$4,339	1.4%	$1.70	—	SPONSORED ADS	44975P103
ENTA	ENANTA PHARMACEUTICALS INC	322,453	$3,341	1.1%	$13.28	-1.5%	COM	29251M106
OTLK	OUTLOOK THERAPEUTICS INC	318,699	$1,702	0.5%	$8.09	-9.5%	COM	69012T305